Systematic benchmarking shows existing transcriptomic predictors for immune checkpoint inhibitor response have limited cross-cohort generalisability and inconsistent biomarker signals.
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2 Pith papers cite this work. Polarity classification is still indexing.
2
Pith papers citing it
citation-role summary
method 1
citation-polarity summary
verdicts
UNVERDICTED 2roles
method 1polarities
use method 1representative citing papers
A stochastic agent-based model integrates tumor and immune cell behaviors to simulate progression and evaluate single and combination cancer therapies.
citing papers explorer
-
Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability
Systematic benchmarking shows existing transcriptomic predictors for immune checkpoint inhibitor response have limited cross-cohort generalisability and inconsistent biomarker signals.
-
A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies
A stochastic agent-based model integrates tumor and immune cell behaviors to simulate progression and evaluate single and combination cancer therapies.